固体瘤微环境中的母细胞:多重作用和有针对性的治疗潜力
Chenglu Lu1, Huiting Zhang2, Ujjal K Bhawal3,4
1Department of Pathology, Hebei Key Laboratory of Molecular Oncology, The Cancer Institute, Tangshan People's Hospital, Tangshan, 063001, China.
Oncology research
|December 22, 2025
概括
瘤微环境 (TME) 中的母细胞 (MC) 具有复杂的作用,可以促进或抑制癌症生长. 了解MCs为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 瘤微环境 (TME) 是一个复杂的生态系统,影响瘤的进展.
- 乳腺细胞 (MCs) 是TME内的关键免疫细胞,具有争论的角色.
- 根据上下文,MCs具有双重调节功能,促进或抑制瘤生长.
研究的目的:
- 系统地审查目前对瘤微环境中的乳腺细胞的理解.
- 强调MC特征和跨瘤类型,病理状态和物种的功能差异.
- 探索MCs作为癌症治疗中的新兴治疗点.
主要方法:
- 综合性文献审查的巨细胞研究在TME.
- 分析MC标记物,激活机制和生物功能.
- 检查细胞相互作用和MCs的治疗调节.
主要成果:
- 乳腺细胞在瘤进展中表现出取决于背景的作用 (支持或反对瘤).
- 在不同癌症类型和物种的MC行为中存在显著的差异.
- 了解MC的进展为有针对性的治疗策略铺平了道路.
结论:
- 巨细胞是TME的关键,多方面的组成部分.
- 准特定的乳腺细胞子集为癌症治疗提供了一个有前途的途径.
- 对MC的进一步研究将为瘤免疫学和治疗的未来方向提供信息.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


